These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 22538023)

  • 1. Botulinum toxin A in the treatment of myofascial pain and dysfunction: the case against its use.
    Laskin DM
    J Oral Maxillofac Surg; 2012 May; 70(5):1240-2. PubMed ID: 22538023
    [No Abstract]   [Full Text] [Related]  

  • 2. Use of botulinum toxin A for treatment of myofascial pain and dysfunction.
    Fallah HM; Currimbhoy S
    J Oral Maxillofac Surg; 2012 May; 70(5):1243-5. PubMed ID: 22538024
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin for chronic migraine.
    Med Lett Drugs Ther; 2011 Jan; 53(1356):7-8. PubMed ID: 21252842
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Sidebottom AJ, Patel AA, Amin J. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Tzanidakis K; Moss C; Gibbons AJ
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):97. PubMed ID: 24148698
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum injection for the management of myofascial pain in the masticatory muscles. A prospective outcome study.
    Sidebottom AJ; Patel AA; Amin J
    Br J Oral Maxillofac Surg; 2013 Apr; 51(3):199-205. PubMed ID: 22871559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of botulinum toxin in treating myofascial pain in bruxers: a controlled placebo pilot study.
    Guarda-Nardini L; Manfredini D; Salamone M; Salmaso L; Tonello S; Ferronato G
    Cranio; 2008 Apr; 26(2):126-35. PubMed ID: 18468272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of botulinum toxin in the treatment of temporomandibular disorders.
    Song PC; Schwartz J; Blitzer A
    Oral Dis; 2007 May; 13(3):253-60. PubMed ID: 17448205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin A in bruxers. One year experience.
    Redaelli A
    Saudi Med J; 2011 Feb; 32(2):156-8. PubMed ID: 21301762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
    Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
    J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: an evidence-based review.
    Ihde SK; Konstantinovic VS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):e1-11. PubMed ID: 17560141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Botulinum Toxin for the Treatment of Myofascial Pain in the Masticatory Muscles.
    Laskin DM
    Oral Maxillofac Surg Clin North Am; 2018 Aug; 30(3):287-289. PubMed ID: 30008341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of botulinum toxin in treating myofascial pain and occlusal force characteristics of masticatory muscles in bruxism.
    Jadhao VA; Lokhande N; Habbu SG; Sewane S; Dongare S; Goyal N
    Indian J Dent Res; 2017; 28(5):493-497. PubMed ID: 29072209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A for the treatment of urinary tract dysfunction in neurological disorders.
    O'Leary M; Dierich M
    Urol Nurs; 2010; 30(4):228-34. PubMed ID: 20949807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of botulinum toxin-A in myofascial pain patients with or without functional disc displacement.
    Kurtoglu C; Gur OH; Kurkcu M; Sertdemir Y; Guler-Uysal F; Uysal H
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1644-51. PubMed ID: 18634953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral palsy and bruxism: Effects of botulinum toxin injections-A randomized controlled trial.
    Cahlin BJ; Lindberg C; Dahlström L
    Clin Exp Dent Res; 2019 Oct; 5(5):460-468. PubMed ID: 31687178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
    von Lindern JJ
    Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of Botulinum toxin type A: an arsenal in dentistry.
    Rao LB; Sangur R; Pradeep S
    Indian J Dent Res; 2011; 22(3):440-5. PubMed ID: 22048586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of severe bruxism with botulinum toxin type A].
    Alonso-Navarro H; Jiménez-Jiménez FJ; Plaza-Nieto JF; Pilo-De la Fuente B; Navacerrada F; Arroyo-Solera M; Calleja M
    Rev Neurol; 2011 Jul; 53(2):73-6. PubMed ID: 21720976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulism toxin: use in disorders of the temporomandibular joint.
    Chang H
    Dent Today; 2005 Dec; 24(12):48, 50-1; quiz 51. PubMed ID: 16396158
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter to the editor: Re: Safety of botulinum toxin type A among children with spasticity secondary to cerebral palsy: a systematic review of randomized clinical trials.
    Dubinsky RM
    Clin Rehabil; 2010 Aug; 24(8):766. PubMed ID: 20702516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.